Whole‑body MRI for metastatic workup in patients diagnosed with cancer

Rashid,Rezheen J.; Tahir,Soran H.; Kakamad,Fahmi H.; Omar,Sami S.; Salih,Abdulwahid M.; Ahmed,Shaho F.; Abdalla,Shalaw H.; Naqar,Sharo; Salih,Rawezh Q.; Kakamad,Suhaib H.; Mohammed,Karukh K.; Mustafa,Shevan M.; Hassan,Marwan N.; Mohammed,Shvan H.

doi:10.3892/mco.2023.2629

Whole‑body MRI for metastatic workup in patients diagnosed with cancer

Authors:
- Rezheen J. Rashid
- Soran H. Tahir
- Fahmi H. Kakamad
- Sami S. Omar
- Abdulwahid M. Salih
- Shaho F. Ahmed
- Shalaw H. Abdalla
- Sharo Naqar
- Rawezh Q. Salih
- Suhaib H. Kakamad
- Karukh K. Mohammed
- Shevan M. Mustafa
- Marwan N. Hassan
- Shvan H. Mohammed
View Affiliations

Affiliations: Department of Oncology, Hiwa Cancer Hospital Centre, Sulaimani Directorate of Health, Sulaimani, Kurdistan 46000, Iraq, Smart Health Tower, Sulaimani, Kurdistan 46000, Iraq, Kscien Organization, Sulaimani, Kurdistan 46000, Iraq
Published online on: March 1, 2023 https://doi.org/10.3892/mco.2023.2629
Article Number: 33
Copyright: © Rashid et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Early diagnosis and appropriate staging workup are crucial for cancer patients. Whole‑body magnetic resonance imaging (WB‑MRI) has been proposed as another practical whole‑body approach for assessing local invasiveness and distant metastases in patients newly diagnosed with cancer. The current study aimed to evaluate the efficacy of WB‑MRI in assessing metastasis in patients newly diagnosed with cancer using histopathologic data as the reference method. A prospective observational study was performed from April 2018 to July 2020. MRI sequences were utilized to acquire anatomical and functional images in three orthogonal planes. The discovery was classified as nodal, skeletal and visceral metastases. Patient‑based analysis was used for visceral metastasis and region‑based for skeletal, systemic and lymph node metastases. A total of 43 consecutive patients (mean age, 56±15.2 years) were assessed successively. In 41 patients, there was a concordance between the WB‑MRI and histological confirmation. The most prevalent site of metastasis was the skeletal system (18 patients). There were 12 individuals with liver metastasis, 10 with lung metastasis and 4 with peritoneal metastasis, with just one brain metastatic lesion found. On WB‑MRI, 38 lymph node groups were deemed positive. Out of the total, 66 skeletal locations contained metastases. The accuracy of WB‑MRI for nodal, skeletal and visceral metastases was (98.45, 100 and 100%, respectively). In conclusion, WB‑MRI in three orthogonal planes, including the diffusion‑weighted MRI with background body signal suppression sequence, may be utilized efficiently and accurately for assessing metastasis staging and may thus be utilized in patients with newly diagnosed cancer.

View Figures

View References

1	Guan X: Cancer metastases: Challenges and opportunities. Acta Pharm Sin B. 5:402–418. 2015.PubMed/NCBI View Article : Google Scholar
2	Heindel W, Gübitz R, Vieth V, Weckesser M, Schober O and Schäfers M: The diagnostic imaging of bone metastases. Dtsch Arztebl Int. 111:741–747. 2014.PubMed/NCBI View Article : Google Scholar
3	Imam K and Bluemke DA: MR imaging in the evaluation of hepatic metastases. Magn Reson Imaging Clin N Am. 8:741–756. 2000.PubMed/NCBI
4	Guimarães MD, Noschang J, Teixeira SR, Santos MK, Lederman HM, Tostes V, Kundra V, Oliveira AD, Hochhegger B and Marchiori E: Whole-body MRI in pediatric patients with cancer. Cancer Imaging. 17(6)2017.PubMed/NCBI View Article : Google Scholar
5	Schlemmer HP, Schäfer J, Pfannenberg C, Radny P, Korchidi S, Müller-Horvat C, Nägele T, Tomaschko K, Fenchel M and Claussen CD: Fast whole-body assessment of metastatic disease using a novel magnetic resonance imaging system: Initial experiences. Invest Radiol. 40:64–71. 2005.PubMed/NCBI View Article : Google Scholar
6	Godinho MV, Lopes FPPL and Costa FM: Whole-body magnetic resonance imaging for the assessment of metastatic breast cancer. Cancer Manag Res. 10:6743–6756. 2018.PubMed/NCBI View Article : Google Scholar
7	Lauenstein TC and Semelka RC: Emerging techniques: Whole-body screening and staging with MRI. J Magn Reson Imaging. 24:489–498. 2006.PubMed/NCBI View Article : Google Scholar
8	Schmidt GP, Haug AR, Schoenberg SO and Reiser MF: Whole-body MRI and PET-CT in the management of cancer patients. Eur Radiol. 16:1216–1225. 2006.PubMed/NCBI View Article : Google Scholar
9	Bisschop C, de Heer EC, Brouwers AH, Hospers GAP and Jalving M: Rational use of ¹⁸F-FDG PET/CT in patients with advanced cutaneous melanoma: A systematic review. Crit Rev Oncol Hematol. 153(103044)2020.PubMed/NCBI View Article : Google Scholar
10	Li B, Li Q, Nie W and Liu S: Diagnostic value of whole-body diffusion-weighted magnetic resonance imaging for detection of primary and metastatic malignancies: A meta-analysis. Eur J Radiol. 83:338–344. 2014.PubMed/NCBI View Article : Google Scholar
11	Nievelstein RA and Littooij AS: Whole-Body MRI in Pediatric Oncology. Img Ped Oncol. 107–135. 2019.
12	Pasoglou V, Michoux N, Tombal B and Lecouvet F: Optimising TNM staging of patients with prostate cancer using WB-MRI. J Belg Soc Radiol. 100(101)2016.PubMed/NCBI View Article : Google Scholar
13	Kwee TC, Takahara T, Ochiai R, Nievelstein RA and Luijten PR: Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): Features and potential applications in oncology. Eur Radiol. 18:1937–1952. 2008.PubMed/NCBI View Article : Google Scholar
14	Puls R, Kühn JP, Ewert R and Hosten N: Whole-body magnetic resonance imaging for staging of lung cancer. Front Radiat Ther Oncol. 42:46–54. 2010.PubMed/NCBI View Article : Google Scholar
15	Akay S, Kocaoglu M, Emer O, Battal B and Arslan N: Diagnostic accuracy of whole-body diffusion-weighted magnetic resonance imaging with 3.0 T in detection of primary and metastatic neoplasms. J Med Imaging Radiat Oncol. 57:274–282. 2013.PubMed/NCBI View Article : Google Scholar
16	Kachewar SG: Using DWIBS MRI technique as an alternative to bone scan or PET scan for whole-body imaging in oncology patients. Acta Radiol. 52(788)2011.PubMed/NCBI View Article : Google Scholar
17	Schmidt GP, Reiser MF and Baur-Melnyk A: Whole-body MRI for the staging and follow-up of patients with metastasis. Eur J Radiol. 70:393–400. 2009.PubMed/NCBI View Article : Google Scholar
18	Schmidt GP, Baur-Melnyk A, Haug A, Heinemann V, Bauerfeind I, Reiser MF and Schoenberg SO: Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT. Eur J Radiol. 65:47–58. 2008.PubMed/NCBI View Article : Google Scholar
19	Sohaib SA, Koh DM, Barbachano Y, Parikh J, Husband JE, Dearnaley DP, Horwich A and Huddart R: Prospective assessment of MRI for imaging retroperitoneal metastases from testicular germ cell tumours. Clin Radiol. 64:362–367. 2009.PubMed/NCBI View Article : Google Scholar
20	Ciliberto M, Maggi F, Treglia G, Padovano F, Calandriello L, Giordano A and Bonomo L: Comparison between whole-body MRI and Fluorine-18-Fluorodeoxyglucose PET or PET/CT in oncology: A systematic review. Radiol Oncol. 47:206–218. 2013.PubMed/NCBI View Article : Google Scholar
21	Barchetti F, Stagnitti A, Megna V, Al Ansari N, Marini A, Musio D, Monti ML, Barchetti G, Tombolini V, Catalano C and Panebianco V: Unenhanced whole-body MRI versus PET-CT for the detection of prostate cancer metastases after primary treatment. Eur Rev Med Pharmacol Sci. 20:3770–3776. 2016.PubMed/NCBI
22	Li B, Li Q, Chen C, Guan Y and Liu S: A systematic review and meta-analysis of the accuracy of diffusion-weighted MRI in the detection of malignant pulmonary nodules and masses. Acad Radiol. 21:21–29. 2014.PubMed/NCBI View Article : Google Scholar
23	Regier M, Schwarz D, Henes FO, Groth M, Kooijman H, Begemann PG and Adam G: Diffusion-weighted MR-imaging for the detection of pulmonary nodules at 1.5 Tesla: Intraindividual comparison with multidetector computed tomography. J Med Imaging Radiat Oncol. 55:266–274. 2011.PubMed/NCBI View Article : Google Scholar
24	Goda HH, Abd Elkareem HA, Ahmed EA, Megally HI, Khalaf MI, Taha AM and Mohamed HEG: Whole body diffusion-weighted MRI in detection of metastasis and lymphoma: A prospective longitudinal clinical study. Egypt J Radiol Nucl Med. 51:1–2. 2020.
25	Eissawy MG, Saadawy AMI, Farag K, Akl T and Kamr WH: Accuracy and diagnostic value of diffusion-weighted whole body imaging with background body signal suppression (DWIBS) in metastatic breast cancer. Egypt J Radiol Nucl Med. 52(74)2021.
26	Iwamura H, Kaiho Y, Ito J, Anan G, Satani N, Matsuura T, Tamura R, Murakami K, Koyama K and Sato M: Evaluation of tumor viability for primary and bone metastases in metastatic castration-resistant prostate cancer using whole-body magnetic resonance imaging. Case Rep Urol. 2018(4074378)2018.PubMed/NCBI View Article : Google Scholar
27	Usuda K, Iwai S, Yamagata A, Iijima Y, Motono N, Matoba M, Doai M, Yamada S, Ueda Y, Hirata K, et al: Diffusion-weighted whole-body imaging with background suppression (DWIBS) is effective and economical for detection of metastasis or recurrence of lung cancer. Thorac Cancer. 12:676–684. 2021.PubMed/NCBI View Article : Google Scholar
28	Paruthikunnan SM, Kadavigere R and Karegowda LH: Accuracy of whole-body DWI for metastases screening in a diverse group of malignancies: Comparison with conventional cross-sectional imaging and nuclear scintigraphy. AJR Am J Roentgenol. 209:477–490. 2017.PubMed/NCBI View Article : Google Scholar
29	Torabi M, Aquino SL and Harisinghani MG: Current concepts in lymph node imaging. J Nucl Med. 45:1509–1518. 2004.PubMed/NCBI
30	Tunariu N, Blackledge M, Messiou C, Petralia G, Padhani A, Curcean S, Curcean A and Koh DM: What's new for clinical whole-body MRI (WB-MRI) in the 21st century. Brit J Radiol. 93(20200562)2020.PubMed/NCBI View Article : Google Scholar
31	Kharuzhyk S, Zhavrid E, Dziuban A, Sukolinskaja E and Kalenik O: Comparison of whole-body MRI with diffusion-weighted imaging and PET/CT in lymphoma staging. Eur Radiol. 30:3915–3923. 2020.PubMed/NCBI View Article : Google Scholar
32	Balbo-Mussetto A, Cirillo S, Bruna R, Gueli A, Saviolo C, Petracchini M, Fornari A, Lario CV, Gottardi D, De Crescenzo A and Tarella C: Whole-body MRI with diffusion-weighted imaging: A valuable alternative to contrast-enhanced CT for initial staging of aggressive lymphoma. Clin Radiol. 71:271–279. 2016.PubMed/NCBI View Article : Google Scholar
33	Albano D, Patti C, La Grutta L, Agnello F, Grassedonio E, Mulè A, Cannizzaro G, Ficola U, Lagalla R, Midiri M and Galia M: Comparison between whole-body MRI with diffusion-weighted imaging and PET/CT in staging newly diagnosed FDG-avid lymphomas. Eur J Radiol. 85:313–318. 2016.PubMed/NCBI View Article : Google Scholar
34	Sigovan M, Akl P, Mesmann C, Tronc F, Si-Mohamed S, Douek P and Boussel L: Benign and malignant enlarged chest nodes staging by diffusion-weighted MRI: An alternative to mediastinoscopy? Brit J Radiol. 91(20160919)2018.PubMed/NCBI View Article : Google Scholar
35	Yang HL, Liu T, Wang XM, Xu Y and Deng SM: Diagnosis of bone metastases: A meta-analysis comparing 18FDG PET, CT, MRI and bone scintigraphy. Eur Radiol. 21:2604–2617. 2011.PubMed/NCBI View Article : Google Scholar
36	Engelhard K, Hollenbach HP, Wohlfart K, von Imhoff E and Fellner FA: Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer. Eur Radiol. 14:99–105. 2004.PubMed/NCBI View Article : Google Scholar
37	Shen G, Deng H, Hu S and Jia Z: Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: A meta-analysis. Skelet Radiol. 43:1503–1513. 2014.PubMed/NCBI View Article : Google Scholar
38	Liu LP, Cui LB, Zhang XX, Cao J, Chang N, Tang X, Qi S, Zhang XL, Yin H and Zhang J: Diagnostic performance of diffusion-weighted magnetic resonance imaging in bone malignancy: Evidence from a meta-analysis. Medicine (Baltimore). 94(e1998)2015.PubMed/NCBI View Article : Google Scholar